SENS trade ideas
SENS Long Trade Setup !🚀 🔥
📊 Breakout: SENS has broken out of a consolidation triangle with strong bullish momentum.
📈 Key Levels:
Entry: $0.9054 ✅
Stop Loss (SL): $0.8476 🛡️
Target 1 (T1): $0.9839 🎯
Target 2 (T2): $1.07 🚀
🔍 Volume Confirmation: High volume adds strength to this bullish breakout.
💡 Opportunity: A great setup to ride the momentum and target potential gains! 💥
#SENS #StockTrading #TradingView #BreakoutTrade #BullishSetup #DayTrading #LongTrade #StockMarket #TechnicalAnalysis #ChartPatterns #MomentumTrading #SwingTrading #TradeSmart #RiskManagement #StockCharts #MarketAnalysis #StockWatch #ProfitableTrading #TrendTrading
Buy Opportunity - Penny Stock3 highs, 2 lows - Next up, upper range of the “megaphone.” Good risk:reward here at current price.
Will we break out or drop further?I've noticed this triangle forming with the lower high resistances and higher low supports. The price action seems to be staying in this range but we are running out of run way. My position is bullish due to the companies progress and forward expectations on upcoming earnings. A breakout to the upside is quite possible but a safe bet would be a trade to the upper bound of the triangle. Let me know your thoughts.
"Sens Stock: Eyeing 1000% Return Potential"Sens Stock: Eyeing 38 Cents for All-Time Low Buy Opportunity
Sens stock, a compelling asset in the realm of healthcare technology, is catching the attention of investors as it approaches the 38-cent mark, representing all-time lows. With the formation of a double bottom and falling wedge pattern, this potential buy opportunity could pave the way for a remarkable turnaround, offering the potential for a 1000% return to previous highs. Let's explore what Sens stock represents and delve into the promising prospects it holds.
Understanding Sens Stock
Sens is a healthcare technology company focused on developing innovative solutions to improve patient care and outcomes. With a portfolio that includes wearable devices, remote monitoring systems, and data analytics platforms, Sens is at the forefront of revolutionizing healthcare delivery and management. Through its cutting-edge technologies, Sens aims to empower patients, healthcare providers, and caregivers alike to make more informed decisions and enhance the quality of care.
The 38-Cent Buy Opportunity
As Sens stock approaches the 38-cent mark, it presents a compelling opportunity for investors to initiate positions at all-time lows. The formation of a double bottom pattern, coupled with a falling wedge, adds further conviction to this potential buy opportunity. By strategically entering the market at this critical juncture, investors may position themselves for substantial gains as the stock seeks to reverse its downtrend and embark on a new bullish trajectory.
Potential for a 1000% Return
The buy opportunity at 38 cents holds significant upside potential for investors eyeing a potential return to previous highs. With the formation of a double bottom and falling wedge pattern signaling a potential trend reversal, Sens stock could experience a dramatic turnaround, offering the potential for a 1000% return to previous highs. This remarkable upside underscores the attractive risk-reward profile of the investment opportunity presented by Sens stock at current levels.
Conclusion: Navigating the Path Forward
In conclusion, Sens stock presents a compelling buy opportunity at 38 cents, representing all-time lows and supported by the formation of a double bottom and falling wedge pattern. As investors eye the potential for a 1000% return to previous highs, prudent risk management strategies are essential to navigate the inherent volatility of the market. By carefully assessing the fundamental strengths of Sens as a healthcare technology company and monitoring technical indicators for signs of a bullish reversal, investors can position themselves strategically to capitalize on the promising prospects offered by Sens stock in the journey ahead.
SENS (Are we there yet)Sens recent earnings was quite good but the stock has sold off anyway. I have been waiting patiently for this moment as we could be reaching the bottoming phase based on the chart analysis of the bearish shark.
What narrative could make it spike up in price?
Please do your DD as this is not a financial advice.
SENS: Short-term Bear and Medium/Long-term BullSometime this week we may see the share price of AMEX:SENS drop to $0.78. Anything lower could indicate a drop out of the trend, but if it holds, a large profit could be made moving into August.
Using a combination of the following 3 scripts:
1. Advanced Price Direction Algorithm
2. DeQuex Algo
3. Moving Average Convergence Divergence
If all 3 give off a green/blue/green pattern, with the MACD barely starting to show a positive evaluation when it occurs, there is a high probability that the trend will continue upwards.
Sens going too $3 by Tuesday AMEX:SENS Sensus Healthcare Inc., is a medical technology company that specializes in developing and commercializing innovative non-invasive treatment solutions for various skin conditions, including non-melanoma skin cancers. Here are a few positive aspects to consider:
Innovative Treatment Solutions: Sensus Healthcare focuses on providing non-invasive and advanced treatment options for skin conditions. Their flagship product, the SRT-100™, offers a non-surgical alternative to traditional surgical procedures for treating non-melanoma skin cancers. This innovative approach can potentially provide patients with effective treatment options while minimizing the risks and complications associated with surgery.
Growing Demand for Non-Invasive Treatments: The healthcare industry is witnessing an increasing demand for non-invasive treatment solutions. Patients are often seeking alternatives to surgery or more aggressive procedures. Sensus Healthcare's focus on non-invasive technologies aligns well with this growing trend and may position the company favorably in the market.
Established Track Record: Sensus Healthcare has been in operation since 2010 and has developed a track record of delivering its innovative solutions to medical professionals. The company has a presence in various countries and has gained recognition within the medical community for its commitment to advancing non-invasive treatment options.
Broad Applications: In addition to non-melanoma skin cancers, Sensus Healthcare's products have potential applications in treating keloids, basal cell carcinoma, and other dermatological conditions. This diversification of applications expands the market opportunity for the company and may contribute to its growth potential.
Ongoing Research and Development: Sensus Healthcare continues to invest in research and development, aiming to enhance and expand its product offerings. The company's commitment to innovation and staying at the forefront of non-invasive treatment technologies could position it for future growth and increased market share.
Gap anyone?2 very critical gaps to fill, 1st @ 2.35 2nd @ 3.35 , I expect both to fill within 90 days , not to mention a bounce off this rev fib would shoot us up to 2.92
SENS GOT FDA APPROVAL AND THIS HAPPENED??!!SENS finally received FDA approval on their 180 continuous glucose monitoring system and the price TANKED! Out of nowhere today we see somewhat of a change.. I believe we are on the upswing now for some violent price action. Take a look!
$SENS PRICE TEST FOR REVERSALwe go bounce at our support 2.18$, We have strong resistant and reversal area at 2.70$, we should have 4h candle to confirm the bullish momentum .
if we didn't hold the above support, we will see buying pressure agin at 1.72$
$SENS mission accomplished...$4 calls in the money now, still have 8 days to expiration. Time to take at least half profits...still has plenty of room to go, but always protect some profits.
$SENS quietly starting the week green...Earnings week, so will be about guidance and discussion on FDA. Holding $4 11/19 calls, will reassess after
$SENS a good week...But just the start ideally, still holding the $4 calls for 11/19. If we have a consolidation week I'll need to extend out to Dec.
$SENS weekly update...Still doing fine here, nice weekly candle set up, no change to my thesis on 11/19 $4 calls...
SENS - Symmetrical Triangle BreakoutOver $4.15 we will see a move to $4.76, $5.20, $5.64.
Resistance at $4.58
SENS has a catalyst in the next 1 - 2 months. You can take 2022 March $4 Calls. I’m holding SENS $2C 01 /20/23 @$2.5 Calls.
$SENS continues up....Breaking out of this triangle, solid move so far this week. Anticipation of FDA approval of 180 day wearable glucose monitor as the driver and potential catalyst for more...also risky for that reason
$SENS peeking out...Starting a potential move out of this triangle, looking for continuation the rest of the week
$SENS still liking this one into Nov...$4 calls at $0.15 still holding, risky as there will be news on FDA approval, but low risk/high reward and I like the chart look
$SENS new ticker...This weekly triangle is looking interesting, just starting to study this stock. Implantable glucose monitoring company...I like the chart and the tech so far...starter position could be 11/19 $4.00 calls at $0.13/$0.15
SENS Senseonics upcoming catalyst! SENS Senseonics is waiting for FDA`s approval for the 180-day version of its Eversense CGM system.
Eversense can generate as much as $200 million in sales by 2025.
HC Wainwright sees a 6usd price target for it.
And let`s not forget it`s a meme stock.
$en$ Cup and Handle formation on the weekly chart...it seems like theres more upside to $4+ range in the coming weeks
